Financial insights of DYAI

MyFinsight

For the quarter ending 2025-09-30, DYAI made $1,164,617 in revenue. -$1,976,012 in net income. Net profit margin of -169.67%.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Total revenue	1,164,617	966,630	393,572	575,996.5
Costs of research and development revenue	254,753	148,457	-	-
Costs of grant revenue	769,250	465,134	-	-
Foreign currency exchange loss	-	-	-7,072	-6,710
Cost of revenue	-	-	297,658	248,387
Research and development	571,872	629,379	494,979	534,191.5
General and administrative	1,481,356	1,436,630	1,596,338	1,614,516.5
Foreign currency exchange loss	12,755	16,098	-	-
Total costs and expenses	3,089,986	2,695,698	2,396,047	2,403,805
Loss from operations	-1,925,369	-1,729,068	-2,002,475	-1,827,808.5
Interest income	63,467	49,127	-	-
Interest expense	-	-	113,562	125,252
Interest expense-Nonrelated Party	85,934	89,456	-	-
Gain on sale of alphazyme	-	0	-	15,660.5
Interest income	-	-	88,458	157,162
Interest expense-Related Party	28,176	24,377	-	-
Total other income (expense), net	-50,643	-64,706	-25,104	47,570.5
Net loss	-1,976,012	-1,793,774	-2,027,579	-1,780,238

Basic net loss per common share	-0.06	-0.06	-0.07	-0.06
Diluted net loss per common share	-0.06	-0.06	-	-
Diluted weighted-average common shares outstanding	34,507,530	30,102,324	-	-